Chaogetu Saren
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chaogetu Saren has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Arata Sakiyama
Laboratory of Phage Biologics, Graduate School of Medicine, Gifu University
1 shared publication - Ken-Ichi Oinuma
Department of Bacteriology, Osaka Metropolitan University Graduate School of Medicine
1 shared publication Mamiko Niki
Department of Bacteriology, Osaka Metropolitan University Graduate School of Medicine
1 shared publication- Masato Suzuki
Antimicrobial Resistance Research Center, National Institute of Infectious Diseases
1 shared publication - Taishi Tsubouchi
Department of Bacteriology, Graduate School of Medicine, Osaka City University, Abeno, Osaka, Japan
1 shared publication Yukihiro Kaneko
Department of Bacteriology, Osaka Metropolitan University Graduate School of Medicine
1 shared publication
Latest Publications
- Open Access
- 11 February 2026
- Published by American Society for Microbiology in mBio
- Vol. 17 (2) , e0236625
Benefits and costs of a hypercapsule and the mechanism of its loss in a clinical isolate of Acinetobacter baumannii
Acinetobacter baumannii is an opportunistic pathogen in which capsule production is closely linked to immune evasion and environmental persistence. Recent studies have described two seemingly contradictory phenomena—increasing prevalence of capsule-overproducing clinical isolates and frequent isolation of capsule-deficient variants. The biological significance of these phenomena remains unclear. In this study, we analyzed a clinical isolate, OCU_Ac16b, which spontaneously gives rise to two phenotypically distinct variants: the L type forming large colonies with a prominent hypercapsule (>1 µm thick), and the S type forming small colonies with a substantially reduced or absent capsule. When L-type cells were cultured in test tubes under low-shaking conditions, S-type variants reproducibly emerged, constituting approximately 40%–80% of the population within 24 h. Whole-genome sequencing revealed that this conversion is driven by distinct mutations in the capsular polysaccharide synthesis cluster, including insertion sequence insertions and a single-nucleotide deletion. Dilution experiments demonstrated that L-to-S conversion mutations arise de novo during liquid culture at sufficiently high rates to account for the rapid and reproducible emergence of S-type variants. Phenotypic characterization demonstrated a biological trade-off, with L-type cells exhibiting enhanced resistance to serum killing, desiccation, and certain β-lactam antibiotics, whereas S-type cells showed superior surface attachment, increased biofilm formation, and a growth advantage under oxygen-limited conditions. Our findings uncover a highly reproducible, mutation-driven capsule switching mechanism that enables rapid phenotypic adaptation to changing environments. This phenotypic heterogeneity has significant implications for pathogenesis, persistence, diagnostic evaluation, and clinical management. IMPORTANCE: Acinetobacter baumannii is a clinically important opportunistic pathogen that exhibits striking phenotypic diversity. In particular, some clinical isolates produce unusually thick capsules, which are thought to contribute to immune evasion and persistence, while others lack the capsule altogether. However, the biological significance of these contrasting phenotypes has remained unclear. We analyzed a clinical isolate that spontaneously gives rise to capsule-deficient variants from a hypercapsulated form. We found that the conversion is driven by spontaneous mutations in capsule biosynthesis genes, including de novo mutations arising during liquid culture, while the expansion of capsule-deficient cells is promoted under oxygen-limited conditions. The two variants differed in serum resistance, desiccation tolerance, growth characteristics, and antibiotic responses, revealing a trade-off between protective barriers and environmental adaptability. These findings provide new insights into how A. baumannii may balance survival strategies through genetic and phenotypic heterogeneity, with potential implications for diagnosis, treatment, and bacterial persistence in clinical settings.
- 11 February 2026
- Published by American Society for Microbiology in mBio
- Vol. 17 (2) , e0236625
Open AccessBenefits and costs of a hypercapsule and the mechanism of its loss in a clinical isolate of Acinetobacter baumannii
Acinetobacter baumannii is an opportunistic pathogen in which capsule production is closely linked to immune evasion and environmental persistence. Recent studies have described two seemingly contradictory phenomena—increasing prevalence of capsule-overproducing clinical isolates and frequent isolation of capsule-deficient variants. The biological significance of these phenomena remains unclear. In this study, we analyzed a clinical isolate, OCU_Ac16b, which spontaneously gives rise to two phenotypically distinct variants: the L type forming large colonies with a prominent hypercapsule (>1 µm thick), and the S type forming small colonies with a substantially reduced or absent capsule. When L-type cells were cultured in test tubes under low-shaking conditions, S-type variants reproducibly emerged, constituting approximately 40%–80% of the population within 24 h. Whole-genome sequencing revealed that this conversion is driven by distinct mutations in the capsular polysaccharide synthesis cluster, including insertion sequence insertions and a single-nucleotide deletion. Dilution experiments demonstrated that L-to-S conversion mutations arise de novo during liquid culture at sufficiently high rates to account for the rapid and reproducible emergence of S-type variants. Phenotypic characterization demonstrated a biological trade-off, with L-type cells exhibiting enhanced resistance to serum killing, desiccation, and certain β-lactam antibiotics, whereas S-type cells showed superior surface attachment, increased biofilm formation, and a growth advantage under oxygen-limited conditions. Our findings uncover a highly reproducible, mutation-driven capsule switching mechanism that enables rapid phenotypic adaptation to changing environments. This phenotypic heterogeneity has significant implications for pathogenesis, persistence, diagnostic evaluation, and clinical management. IMPORTANCE: Acinetobacter baumannii is a clinically important opportunistic pathogen that exhibits striking phenotypic diversity. In particular, some clinical isolates produce unusually thick capsules, which are thought to contribute to immune evasion and persistence, while others lack the capsule altogether. However, the biological significance of these contrasting phenotypes has remained unclear. We analyzed a clinical isolate that spontaneously gives rise to capsule-deficient variants from a hypercapsulated form. We found that the conversion is driven by spontaneous mutations in capsule biosynthesis genes, including de novo mutations arising during liquid culture, while the expansion of capsule-deficient cells is promoted under oxygen-limited conditions. The two variants differed in serum resistance, desiccation tolerance, growth characteristics, and antibiotic responses, revealing a trade-off between protective barriers and environmental adaptability. These findings provide new insights into how A. baumannii may balance survival strategies through genetic and phenotypic heterogeneity, with potential implications for diagnosis, treatment, and bacterial persistence in clinical settings.